GSK rejects three Unilever bids to buy consumer healthcare arm, says unit was “fundamentally undervalued”

Sunday, January 16, 2022 United Kingdom-based pharmaceutical giant GlaxoSmithKline (GSK) confirmed today it had rejected three “unsolicited, conditional and non-binding proposals” by Unilever to acquire its Consumer Healthcare division, including one bid of GBP50 billion …